Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-30

Clinical Trial Update: A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating tofacitinib in people with psoriatic arthritis, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tofacitinib (tofacitinib)

Snippet

Sponsor: Pfizer | Conditions: Psoriatic Arthritis | Status: COMPLETED | Results posted: 2025-03-30